DiaMedica Therapeutics Inc. (DMAC)Healthcare | Biotechnology | Minneapolis, United States | NasdaqCM
7.49 USD
-0.18
(-2.347%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 7.49 |
Hot Take ↕ | July 11, 2026, 3:12 a.m. EDT
The immediate outlook is driven by aggressive insider accumulation and a sharp technical rebound, yet the underlying business remains a speculative gamble. While insiders have purchased nearly half the float recently and the stock has rallied off its lows, the company is burning cash with negative free cash flow and no earnings. The balance sheet is technically strong due to massive cash reserves, but this is typical for early-stage biotechs rather than a sign of profitability. The lack of a dividend and the reliance on future clinical trial results mean this is purely a binary bet on drug approval. The options market reflects this sentiment, with traders positioning for a continued upward move despite the weak statistical forecast models. For investors, this is a high-risk momentum play dependent on upcoming clinical milestones, not a fundamental value investment. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.064149 |
| AutoARIMA | 0.066123 |
| AutoETS | 0.066216 |
| AutoTheta | 0.074444 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 5.38 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.029 |
| Excess Kurtosis | 0.73 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.449 |
| Market Cap | 403,586,240 |
| Forward P/E | -8.51 |
| Beta | 0.97 |
| Website | https://www.diamedica.com |
As of July 11, 2026, 3:12 a.m. EDT: Speculators are heavily skewed toward buying calls, with open interest concentrated in the July 17 expiration where out-of-the-money strikes show significantly higher volume and open interest relative to in-the-money positions. This suggests a bullish bias targeting a move above the current price. Conversely, put buyers are sparse, with notable open interest only at deep out-of-the-money strikes for October expirations, indicating limited hedging demand against a crash.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.9127182 |
| Address1 | 301 Carlson Parkway |
| Address2 | Suite 210 |
| All Time High | 44.94 |
| All Time Low | 0.814 |
| Ask | 9.48 |
| Ask Size | 2 |
| Audit Risk | 9 |
| Average Daily Volume10 Day | 361,460 |
| Average Daily Volume3 Month | 197,859 |
| Average Volume | 197,859 |
| Average Volume10Days | 361,460 |
| Beta | 0.967 |
| Bid | 5.46 |
| Bid Size | 2 |
| Board Risk | 5 |
| Book Value | 0.877 |
| City | Minneapolis |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 7.49 |
| Current Ratio | 9.11 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 7.64 |
| Day Low | 7.35 |
| Debt To Equity | 0.449 |
| Display Name | DiaMedica Therapeutics |
| Dividend Date | 1,542,240,000 |
| Earnings Call Timestamp End | 1,778,155,200 |
| Earnings Call Timestamp Start | 1,778,155,200 |
| Earnings Timestamp | 1,778,097,600 |
| Earnings Timestamp End | 1,778,097,600 |
| Earnings Timestamp Start | 1,778,097,600 |
| Ebitda | -36,692,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -9.606 |
| Enterprise Value | 352,467,264 |
| Eps Current Year | -0.83 |
| Eps Forward | -0.88 |
| Eps Trailing Twelve Months | -0.71 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 6.2706 |
| Fifty Day Average Change | 1.2193999 |
| Fifty Day Average Change Percent | 0.19446304 |
| Fifty Two Week Change Percent | 91.27182 |
| Fifty Two Week High | 10.4195 |
| Fifty Two Week High Change | -2.9295006 |
| Fifty Two Week High Change Percent | -0.2811556 |
| Fifty Two Week Low | 3.6 |
| Fifty Two Week Low Change | 3.8899999 |
| Fifty Two Week Low Change Percent | 1.0805556 |
| Fifty Two Week Range | 3.6 - 10.4195 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,344,000,600,000 |
| Float Shares | 28,768,318 |
| Forward Eps | -0.88 |
| Forward P E | -8.511363 |
| Free Cashflow | -18,008,376 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 35 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.27736 |
| Held Percent Institutions | 0.37849 |
| Implied Shares Outstanding | 53,883,345 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,542,240,000 |
| Last Split Factor | 1:20 |
| Long Business Summary | DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. |
| Long Name | DiaMedica Therapeutics Inc. |
| Market | us_market |
| Market Cap | 403,586,240 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_4382397 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -35,101,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 413,285,256 |
| Number Of Analyst Opinions | 4 |
| Open | 7.58 |
| Operating Cashflow | -30,995,000 |
| Operating Margins | 0.0 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Phone | 763 496 5454 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 7.49 |
| Post Market Time | 1,783,981,118 |
| Previous Close | 7.67 |
| Price Eps Current Year | -9.0240965 |
| Price Hint | 2 |
| Price To Book | 8.540479 |
| Profit Margins | 0.0 |
| Quick Ratio | 8.983 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.18 |
| Regular Market Change Percent | -2.34681 |
| Regular Market Day High | 7.64 |
| Regular Market Day Low | 7.35 |
| Regular Market Day Range | 7.35 - 7.64 |
| Regular Market Open | 7.58 |
| Regular Market Previous Close | 7.67 |
| Regular Market Price | 7.49 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 164,437 |
| Return On Assets | -0.49960998 |
| Return On Equity | -0.86467004 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 2 |
| Shares Outstanding | 53,883,345 |
| Shares Percent Shares Out | 0.096599996 |
| Shares Short | 5,206,327 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 4,868,646 |
| Short Name | DiaMedica Therapeutics Inc. |
| Short Percent Of Float | 0.144 |
| Short Ratio | 22.43 |
| Source Interval | 15 |
| State | MN |
| Symbol | DMAC |
| Target High Price | 25.0 |
| Target Low Price | 11.0 |
| Target Mean Price | 15.5 |
| Target Median Price | 13.0 |
| Total Cash | 51,331,000 |
| Total Cash Per Share | 0.953 |
| Total Debt | 212,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.71 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.19285 |
| Two Hundred Day Average Change | 0.29714966 |
| Two Hundred Day Average Change Percent | 0.04131181 |
| Type Disp | Equity |
| Volume | 164,437 |
| Website | https://www.diamedica.com |
| Zip | 55,305 |